Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$72.36 - $113.1 $10,564 - $16,512
146 New
146 $11,000
Q2 2022

Jul 27, 2022

SELL
$87.2 - $114.05 $17,963 - $23,494
-206 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$94.19 - $124.49 $19,403 - $25,644
206 New
206 $23,000
Q2 2019

Jul 12, 2019

SELL
$39.26 - $54.21 $3,140 - $4,336
-80 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$29.84 - $43.92 $2,387 - $3,513
80 New
80 $3,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.